REBLOZYL® (luspatercept-aamt) for the Treatment of Anaemia Associated with Beta-Thalassemia

Image 3-REBLOZYL® (luspatercept-aamt) for the Treatment of Beta-Thalassemia-Associated Anaemia
REBLOZYL® (luspatercept-aamt) is administered through a subcutaneous injection with a starting dose of 1mg/kg. Credit: Celgene Corporation.